株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療向け人工知能 (AI) の世界市場

The Market for Artificial Intelligence (AI) in Healthcare

発行 Kalorama Information 商品コード 914798
出版日 ページ情報 英文 142 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
医療向け人工知能 (AI) の世界市場 The Market for Artificial Intelligence (AI) in Healthcare
出版日: 2019年09月25日 ページ情報: 英文 142 Pages
概要

当レポートでは、世界の医療向け人工知能 (AI) 市場について分析し、全体的な市場規模の動向見通し (今後6年間分) や、用途別・コンポーネント別の詳細動向、地域別の市場シェア構造、主要国/地域の今後の需要動向見通し、主要企業のプロファイルと業績、主な市場促進・抑制要因、といった情報を取りまとめてお届けいたします。

第1章 エグゼクティブサマリー

第2章 人工知能 (AI):概論

  • 産業概要
    • 人工知能 (AI) のムーブメント
    • 医療業界はAIとの一体化にどう備えているのか?
    • 用途別の市場区分
    • コンポーネント別の市場区分
    • 地域別の市場区分
  • AI技術
  • 略語・定義
  • 企業動向:概略
    • 大手企業:分野別の業績構造
    • AI技術の発展

第3章 PHM (Population Health Management) 向け人工知能 (AI)

  • 概要
  • 産業・技術動向
  • コンポーネント別の概況と分析
  • 企業分析

第4章 医療用ワークフロー・ソリューションにおける人工知能 (AI)

第5章 医用画像・診断・疾患管理における人工知能 (AI)

第6章 創薬・医薬品開発における人工知能 (AI)

第7章 リスク分析・サイバーセキュリティ・その他の用途における人工知能 (AI)

第8章 世界の医療向け人工知能 (AI) 市場

  • 世界市場の促進要因
    • 人口高齢化
    • 慢性疾患の患者数増加
    • 死亡率の上昇
    • 医療費の対GDP比の上昇
  • 世界の医療向けAI市場

第9章 主要企業のプロファイル:医療向けAI市場

  • 概要
  • AICURE
    • 企業概要
    • 製品
    • 業績
  • AMAZON WEB SERVICES, INC.
  • ATOMWISE, INC U.S.
  • BAY LABS, INC
  • BERG HEALTH
  • BIOXCEL THERAPEUTICS, INC.
  • CISCO SYSTEMS, INC.
  • CLARIFY HEALTH SOLUTIONS
  • CLOUDMEDX
  • CYCLICA
  • DEEP GENOMICS, INC
  • ENLITIC
  • GE HEALTHCARE, INC.
  • GOOGLE, INC. (ALPHABET, INC.)
  • IBM, INC.
  • ICARBONX
  • INTEL, INC.
  • KONINKLINJKE PHILIPS, INC.
  • MEDTRONIC, INC.
  • MICROSOFT, INC.
  • NVIDIA, INC.
  • QVENTUS, INC
  • RECURSION PHARMACEUTICALS, INC.
  • SAS INSTITUTE, INC
  • SIEMENS HEALTHINEERS GMBH
  • STRYKER, INC
  • VERINT NEXT IT
  • WELLTOK, INC.
  • ZEBRA MEDICAL VISION
目次
Product Code: 19-042

CUSTOM ABSTRACT For Pub Site Issues facing the healthcare industry are challenging and complex, including staff reductions, increased service demands and funding cuts. It is not surprising then that many are looking to the advanced solutions that artificial intelligence (AI) can offer in this realm.

Kalorama Information's report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in diagnostics and other areas:

  • Global AI in Healthcare Market, 2019-2024
  • Global AI Market and Healthcare AI Performance Expectations, 2019 and 2024 ($ Millions)
  • Market Share for AI Healthcare by Applications, 2019 (Population Health; Workflow Solutions; Imaging, Diagnostics and Disease Management, Drug Discovery & Development; Other AI)
  • AI Healthcare Market Component Distribution by Application Segment, 2019 (%) (Population Health; Workflow Solutions; Imaging, Diagnostics and Disease Management, Drug Discovery & Development; Other AI)
  • AI Healthcare Market Distribution by Global Region, 2019 (%) (U.S., Europe, China, Japan, Rest of Asia Pacific, Latin America, Rest of World)
  • AI in Healthcare Demand by Country/Region, 2019 and 2024 ($ millions) (United States, Europe, China, Japan, Other Asia Pacific, Latin America, RoW)

Healthcare applications that are gaining traction utilizing AI include the following segments, which are estimated and forecasted in the report:

  • Population health
    • AI Population Health, Market Opportunity, 2019 and 2024
    • Population Health and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • AI and Population Health Competitor Review, 2019 (%)
  • Workflow solutions
    • AI Healthcare Workflow Solutions, Market Opportunity, 2019 and 2024
    • Workflow Solutions and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • AI and Workflow Solutions: Competitor Review, 2019 (%)
  • Imaging, diagnostics and disease management
    • AI Imaging, Diagnostics and DM, Market Opportunity, 2019 and 2024
    • AI Imaging, Diagnostics and Disease Management (DM) Estimated Distribution of Sales, 2019 (%)
    • Imaging, Diagnostics, DM and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Imaging AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Diagnostics AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Disease Management AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • AI and Imaging, Diagnostic, and DM: Competitor Review, 2019 (%)
  • Drug discovery and development
    • AI Drug Discovery & Development, Market Opportunity, 2019 and 2024
    • Drug Discovery & Development and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • AI and Drug Discovery & Development: Competitor Review, 2019 (%)
  • Other applications such as risk analysis fraud protection, cybersecurity, data mining and nutrition and fitness
    • Risk Analytics, Cybersecurity and Other AI Market Opportunity, 2019 and 2024 ($ millions)
    • Risk Analytics, Cybersecurity and Other AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Risk Analytics, Cybersecurity and Other AI Applications: Competitor Review, 2019 (%)

Future prospects for AI in healthcare include health assistance and medication management, precision medicine applications, drug creation and support in helping people make healthier choices and decisions. The report lists scores of examples of real-world AI offerings, discusses the effects of AI on traditional healthcare delivery and looks at patents in various segments of the market.

The AI market consists of a wide range of company types: tech giants, pharmaceutical and biotechnology leaders, medical device companies and imaging vendors, as well as emerging companies that often do the heavy lifting in development and early incubation of how to apply AI in the healthcare field. The report examines company participation by market segment; estimated investor funding, private company focus ($ millions); and estimated market participation by leaders in AI healthcare, by application, 2019 (% market share). The Market for Artificial Intelligence (AI) in Healthcare also profiles these following companies active in the market:

  • AiCure
  • Amazon Web Services, Inc.
  • Atomwise, Inc U.S.
  • Bay Labs, Inc
  • Berg Health
  • BioXcel Therapeutics, Inc.
  • Cisco Systems, Inc.
  • Clarify Health Solutions
  • CloudMedX
  • Cyclica
  • Deep Genomics, Inc
  • Enlitic
  • GE Healthcare, Inc.
  • Google, Inc. (Alphabet, Inc.)
  • IBM, Inc.
  • iCarbonX
  • Intel, Inc.
  • Koninklinjke Philips, Inc.
  • Medtronic, Inc.
  • Microsoft, Inc.
  • Nvidia, Inc.
  • Qventus, Inc
  • Recursion Pharmaceuticals, Inc.
  • SAS Institute, Inc
  • Siemens Healthineers GmbH
  • Stryker, Inc
  • Verint Next IT
  • Welltok, Inc.
  • Zebra Medical Vision

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
  • MARKET REVIEW
    • Figure 1-1: Global AI in Healthcare Market, 2019-2024
  • COMPETITORS
    • Table 1-1: Company Participation by Market Segment
  • SCOPE AND METHODOLOGY
  • RECENT COMPANY DEVELOPMENTS IN AI IN HEALTHCARE
    • Copan Diagnostics: Performing Culture Plate Analysis
    • Sense.ly: Avatar Nurse
    • GE Healthcare: AI-Powered Hospital Command Centers
    • Google DeepMind: Breaking the Black Box of Clinical Practice
    • CareDX and Predigraft: Transplant Testing Risk
    • Grail: Machine Learning on Cancer Mutations
    • AI Cure: Boosting Medication Adherence in Trials
    • Freenome: Computational Biology and Machine Learning for Cancer Detection
    • ARUP-Techcyte: Detection of Parasites and Ova
    • Atomwise: AI Speeds up UHTS
    • Recursion Pharmaceuticals: AI-Powered Biology at Scale
    • Careskore: Taking In the Patient's Data Picture
    • CompCyst: Big Increase in Identification of Benign Cysts
    • Berg: Appling Intelligence to Biomarker Discovery
    • Deep Genomics: AI Drug Discovery Workbench
    • Propeller Health: Smart Inhaler Devices
    • MedAware: AI Physician Alerts Prior to Prescription
    • Philips Pathology Enhancing Tool
    • Babylon Health: AI Decides When to Refer Patient to Video Doctor
    • Bay Echo Labs: FDA-cleared EF Calculation
    • Seegene: AI-Inspired Molecular Diagnostics
    • Ibex Medica: Digital Pathology Review
    • Subtle Medical: Deep Learning on Scans
    • Clever Culture: FDA Cleared Automation of Sample Interpretation
    • Medtronic: AI Fights Diabetes
    • Qiagen: Interpretation of Large Volumes of Data
    • KidneyIntelX: Improved Kidney Testing
    • Hitachi: Patient Risk Detection
    • PredictImmune: Irritable Bowel Disease Predictive Assay

CHAPTER 2: INTRODUCTION TO ARTIFICIAL INTELLIGENCE

  • INDUSTRY OVERVIEW
    • The Artificial Intelligence Movement
      • Figure 2-1: Artificial Intelligence (Machine Learning) Patents Issued in the United States by Year, 1976-2019
    • How Does the Health Industry Stack Up in AI Integration?
      • Figure 2-2: AI Issued Patents in the United States with Direct Healthcare Application by Year, 1976-2019
      • Figure 2-3: Global AI Market and Healthcare AI Performance Expectations, 2019 and 2024 ($ Millions)
    • Market Breakdown by Application
      • Figure 2-4: Market Share for AI Healthcare by Applications, 2019 (Population Health; Workflow Solutions; Imaging, Diagnostics and Disease Management, Drug Discovery & Development; Other AI)
    • Market Breakdown by Component
      • Figure 2-5: AI Healthcare Market Component Distribution by Application Segment, 2019 (%) (Population Health; Workflow Solutions; Imaging, Diagnostics and Disease Management, Drug Discovery & Development; Other AI)
    • Regional Market Breakdown
      • Figure 2-6: AI Healthcare Market Distribution by Global Region, 2019 (%) (U.S., Europe, China, Japan, Rest of Asia Pacific, Latin America, Rest of World)
  • AI TECHNOLOGIES
    • Table 2-1: Examples of AI Healthcare Patents Issued
  • ABBREVIATIONS AND DEFINITIONS
  • COMPETITIVE SUMMARY
    • Table 2-2: Estimated Investor Funding, Private Company Focus ($ Millions)
    • The Leaders: Market Application Review
    • Table 2-3: Estimated Market Participation by Leaders in AI Healthcare, by Application, 2019 (% Market Share)
    • AI Technology Development
    • Figure 2-7: AI Technology Patents by Company with Current or Potential Health or Medical Applications (data through September 1, 2019)

CHAPTER 3: ARTIFICIAL INTELLIGENCE: POPULATION HEALTH

  • OVERVIEW
    • Figure 3-1: AI Population Health, Market Opportunity, 2019 and 2024
  • INDUSTRY AND TECHNOLOGY TRENDS
  • COMPONENT REVIEW AND ANALYSIS
    • Table 3-1: Population Health and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
  • COMPETITOR ANALYSIS
    • Figure 3-2: AI and Population Health Competitor Review, 2019 (%)

CHAPTER 4: AI IN HEALTHCARE WORKFLOW SOLUTIONS

  • OVERVIEW
    • Figure 4-1: AI Healthcare Workflow Solutions, Market Opportunity, 2019 and 2024
  • INDUSTRY AND TECHNOLOGY TRENDS
  • COMPONENT REVIEW AND ANALYSIS
    • Table 4-1: Workflow Solutions and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
  • PRODUCTS AND COMPETITORS
  • COMPETITOR ANALYSIS
    • Figure 4-2: AI and Workflow Solutions: Competitor Review, 2019 (%)

CHAPTER 5: AI IN IMAGING, DIAGNOSTICS, AND DISEASE MANAGEMENT

  • OVERVIEW
    • Imaging
    • Diagnostics
    • Disease Management
      • Figure 5-1: AI Imaging, Diagnostics and DM, Market Opportunity, 2019 and 2024
  • INDUSTRY AND TECHNOLOGY TRENDS
    • Imaging
    • Diagnostics
    • Disease Management
      • Figure 5-2: AI Imaging, Diagnostics and Disease Management (DM) Estimated Distribution of Sales, 2019 (%)
  • COMPONENT REVIEW AND ANALYSIS
    • Table 5-1: Imaging, Diagnostics, DM and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Table 5-2: Imaging AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions).
    • Table 5-3: Diagnostics AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
    • Table 5-4: Disease Management AI Market by Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
  • PRODUCTS AND COMPETITORS
    • Diagnostics
    • Disease Management
  • COMPETITOR ANALYSIS
    • Figure 5-3: AI and Imaging, Diagnostic, and DM: Competitor Review, 2019 (%)

CHAPTER 6: AI IN DRUG DISCOVERY AND DEVELOPMENT

  • OVERVIEW
    • Figure 6-1: AI Drug Discovery & Development, Market Opportunity, 2019 and 2024
  • INDUSTRY AND TECHNOLOGY TRENDS
  • COMPONENT REVIEW AND ANALYSIS
    • Table 6-1: Drug Discovery & Development and AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
  • PRODUCTS AND COMPETITORS
  • COMPETITOR ANALYSIS
    • Figure 6-2: AI and Drug Discovery & Development: Competitor Review, 2019 (%)

CHAPTER 7: AI IN RISK ANALYTICS, CYBERSECURITY AND OTHER APPLICATIONS

  • OVERVIEW
    • Figure 7-1: Risk Analytics, Cybersecurity and Other Market Opportunity, 2019 and 2024.
  • INDUSTRY AND TECHNOLOGY TRENDS
  • COMPONENT REVIEW AND ANALYSIS
    • Table 7-1: Risk Analytics, Cybersecurity and Other AI Component (Hardware, Software, Services) Analysis, 2019 ($ millions)
  • PRODUCTS AND COMPETITORS
    • Risk Analytics
    • Fraud Protection
    • Cybersecurity
    • Data Mining
    • Nutrition and Fitness
    • Table 7-2: Risk Analytics, Cybersecurity and Other AI Market by Product Segment, 2019 and 2024 ($ millions)
  • COMPETITOR ANALYSIS
    • Figure 7-2: Risk Analytics, Cybersecurity and Other AI Applications: Competitor Review, 2019 (%)

CHAPTER 8: GLOBAL AI IN HEALTHCARE MARKETS

  • GLOBAL MARKET DRIVERS.
    • Aging Population
    • Figure 8-1: Global Population Trends, Total Population vs. Age 65+ Population, 2000-2050
    • Figure 8-2: Growth in Total Population vs. Aging Population, 2018-2030
    • Increase in Chronic Disease
    • Figure 8-3: Global Prevalence of Disease, 2000, 2015 and Projected 2030 (Hypertension, Diabetes Mellitus, Depresson, Asthma, Coronary Heart Disease / Ischemic Heart Disease, COPD, Epilepsy, Alzheimer's Disease, HIV / AIDS, Stroke Survivors, Cancer, Tuberculosis, Parkinson's Disease, ESRD)
    • Increasing Death Rates
    • Figure 8-4: Global Death Rate Increase 2018-2030 (%) (UAE, S. Korea, Saudi Arabia, Singapore, Malyasia, Chile, Israel, Iran, Taiwan, Venezuela, Australia, Canada, New Zealand, Mexico, Iraq, Turkey, Bangladesh,
    • China, Brazil, Vietnam, Netherlands, Philippines, Indonesia, Thailand, Switzerland, Egypt, Slovenia, United States, Sweden).
    • Health Expenditures in Relation to GDP
    • Figure 8-5: Global Health Spending as a Percentage of GDP, by Country, 2018 (%) (Australia, Canada, Chile, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Mexico, Netherlands, New Zealand, Poland, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States)
  • GLOBAL MARKET FOR AI IN HEALTHCARE
    • Table 8-1: AI in Healthcare Demand by Country/Region, 2019 and 2024 ($ millions) (United States, Europe, China, Japan, Other Asia Pacific, Latin America, RoW)

CHAPTER 9: ARTIFICIAL INTELLIGENCE IN HEALTHCARE PROFILES

  • OVERVIEW
    • Figure 9-1: AI Healthcare Companies by Headquarter Location
  • AICURE
    • Table 9-1: AiCure Corporate Summary
    • Company Overview
    • Products
  • AMAZON WEB SERVICES, INC.
    • Table 9-2: Amazon Web Services Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-3: Amazon Revenues 2017-2019 (in millions $)
  • ATOMWISE, INC U.S.
    • Table 9-4: Atomwise Corporate Summary
    • Company Overview
    • Products
  • BAY LABS, INC
    • Table 9-5: Bay Labs Corporate Summary
    • Company Overview
    • Products
  • BERG HEALTH
    • Table 9-6: Berg Health Corporate Summary
    • Company Overview
    • Products
  • BIOXCEL THERAPEUTICS, INC.
    • Table 9-7: BioXcel Therapeutics Corporate Summary
    • Company Overview
    • Products
  • CISCO SYSTEMS, INC.
    • Table 9-8: Cisco Systems Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-9: Cisco Revenues 2017-2019 (in millions $)
  • CLARIFY HEALTH SOLUTIONS
    • Table 9-10: Clarify Health Solutions Corporate Summary
    • Company Overview
    • Products
  • CLOUDMEDX.
    • Table 9-11: CloudMedX Corporate Summary
    • Company Overview
    • Products
  • CYCLICA
    • Table 9-12: Cyclica Corporate Summary
    • Company Overview
    • Products
  • DEEP GENOMICS, INC
    • Table 9-13: Deep Genomics Corporate Summary
    • Company Overview
    • Products
  • ENLITIC
    • Table 9-14: Enlitic Corporate Summary
    • Company Overview
    • Products
  • GE HEALTHCARE, INC.
    • Table 9-15: GE Healthcare Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-16: GE Healthcare Revenues 2017-2019 (in billions $)
  • GOOGLE, INC. (ALPHABET, INC.)
    • Table 9-17: Google Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-18: Google Revenues 2017-2019 (in millions $)
  • IBM, INC.
    • Table 9-19: IBM Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-20: IBM Revenues 2017-2019 (in millions $)
  • ICARBONX
    • Table 9-21: iCarbonX Corporate Summary
    • Company Overview
    • Products
  • INTEL, INC.
    • Table 9-22: Intel Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-23: Intel Revenues 2017-2019 (in millions $)
  • KONINKLINJKE PHILIPS, INC.
    • Table 9-24: Koninklinjke Philips Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-25: Koninklijke Philips Revenues 2017-2019 (in millions $)
  • MEDTRONIC, INC.
    • Table 9-26: Medtronic Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-27: Medtronic Revenues 2017-2019 (in millions $)
  • MICROSOFT, INC.
    • Table 9-28: Microsoft Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-29: Microsoft Revenues 2017-2019 (in millions $)
  • NVIDIA, INC.
    • Table 9-30: Nvidia Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-31: Nvidia Revenues 2017-2019 (in millions $)
  • QVENTUS, INC
    • Table 9-32: Qventus Corporate Summary
    • Company Overview
    • Products
  • RECURSION PHARMACEUTICALS, INC.
    • Table 9-33: Recursion Pharmaceuticals Corporate Summary
    • Company Overview
    • Products
  • SAS INSTITUTE, INC
    • Table 9-34: SAS Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-35: SAS Institute Revenues 2017-2019 (in millions $)
  • SIEMENS HEALTHINEERS GMBH
    • Table 9-36: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-37: Siemens Healthineers Revenues 2017-2019 (in millions $)
  • STRYKER, INC
    • Table 9-38: Stryker Corporate Summary
    • Company Overview
    • Products
    • Performance Review
    • Table 9-39: Stryker Revenues 2017-2019 (in millions $)
  • VERINT NEXT IT
    • Table 3-40: Verint Next IT Corporate Summary
    • Company Overview
    • Products
  • WELLTOK, INC.
    • Table 9-41: Welltok Corporate Summary
    • Company Overview
    • Products
  • ZEBRA MEDICAL VISION
    • Table 9-42: Zebra Medical Vision Corporate Summary
    • Company Overview
    • Products
Back to Top